Percutaneous Ethanol Intratumoral Injection for Treatment of Small Primary Liver Cancer：Summary of 240 Cases

摘要

Objective To evaluate the therapeutic effects of percutaneous ethanol intratumoral injection(PETT) for treatment of small primary liver cancer(SPLC). Methods 240 patients with surgically or pathologically proved SPLC(<3 cm in diameter)were treated by PETT(under the guidance of B-ultrasound).Of the 240 patients ,163 had recurrent liver cancer,55 had inoperable liver cancer because of cardiac ,pulmonary ,hepat-ic and renal dydfunctions or due to the close proximity of trmor to the major vessels,and 22 refused to receive surgical resection.In 40 pa-tients who received surgical resection after PETT treatment, the resected tumors were pathologically evaluated for necrotic status and the pa-tients were followed up postoperatively.Results Postoperative1-,2- and 3-year survival rate of the 240 patients was 94.9%,84.2% and 66.3% respectively.Conclusion PETTcan be used as a non-invasive treatment for SPLC,and preoperative PETT appears to be helpful in reducing recurrence of postoperative liver cancer.